 BOSTON, Jan. 04, 2021 GLOBE NEWSWIRE -- Galecto, Inc. NASDAQ: GLTO, a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that Hans Schambye, Chief Executive Officer, will participate in two panel discussions at the LifeSci Partners 10th Annual Healthcare Corporate Access Event, which is being held virtually from January 6-8 and 11-14. 